Toll-like receptor 2 mediates ischemia-reperfusion injury of the small intestine in adult mice. 2014

Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
Department of Gastroenterology, Osaka City University Graduate School of Medicine, Osaka, Japan.

Toll-like receptor 2 (TLR2) recognizes conserved molecular patterns associated with both gram-negative and gram-positive bacteria, and detects some endogenous ligands. Previous studies demonstrated that in ischemia-reperfusion (I/R) injury of the small intestine, the TLR2-dependent signaling exerted preventive effects on the damage in young mice, but did not have a significant effect in neonatal mice. We investigated the role of TLR2 in adult ischemia-reperfusion injury in the small intestine. Wild-type and TLR2 knockout mice at 16 weeks of age were subjected to intestinal I/R injury. Some wild-type mice received anti-Ly-6G antibodies to deplete circulating neutrophils. In wild-type mice, I/R induced severe small intestinal injury characterized by infiltration by inflammatory cells, disruption of the mucosal epithelium, and mucosal bleeding. Compared to wild-type mice, TLR2 knockout mice exhibited less severe mucosal injury induced by I/R, with a 35%, 33%, and 43% reduction in histological grading score and luminal concentration of hemoglobin, and the numbers of apoptotic epithelial cells, respectively. The I/R increased the activity of myeloperoxidase (MPO), a marker of neutrophil infiltration, and the levels of mRNA expression of tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), and cyclooxygenase-2 (COX-2) in the small intestine of the wild-type mice by 3.3-, 3.2-, and 13.0-fold, respectively. TLR2 deficiency significantly inhibited the I/R-induced increase in MPO activity and the expression of mRNAs for TNF-α and ICAM-1, but did not affect the expression of COX-2 mRNA. I/R also enhanced TLR2 mRNA expression by 2.9-fold. TLR2 proteins were found to be expressed in the epithelial cells, inflammatory cells, and endothelial cells. Neutrophil depletion prevented intestinal I/R injury in wild-type mice. These findings suggest that TLR2 may mediate I/R injury of the small intestine in adult mice via induction of inflammatory mediators such as TNF-α and ICAM-1.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007421 Intestine, Small The portion of the GASTROINTESTINAL TRACT between the PYLORUS of the STOMACH and the ILEOCECAL VALVE of the LARGE INTESTINE. It is divisible into three portions: the DUODENUM, the JEJUNUM, and the ILEUM. Small Intestine,Intestines, Small,Small Intestines
D009195 Peroxidase A hemeprotein from leukocytes. Deficiency of this enzyme leads to a hereditary disorder coupled with disseminated moniliasis. It catalyzes the conversion of a donor and peroxide to an oxidized donor and water. EC 1.11.1.7. Myeloperoxidase,Hemi-Myeloperoxidase,Hemi Myeloperoxidase
D004847 Epithelial Cells Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells. Adenomatous Epithelial Cells,Columnar Glandular Epithelial Cells,Cuboidal Glandular Epithelial Cells,Glandular Epithelial Cells,Squamous Cells,Squamous Epithelial Cells,Transitional Epithelial Cells,Adenomatous Epithelial Cell,Cell, Adenomatous Epithelial,Cell, Epithelial,Cell, Glandular Epithelial,Cell, Squamous,Cell, Squamous Epithelial,Cell, Transitional Epithelial,Cells, Adenomatous Epithelial,Cells, Epithelial,Cells, Glandular Epithelial,Cells, Squamous,Cells, Squamous Epithelial,Cells, Transitional Epithelial,Epithelial Cell,Epithelial Cell, Adenomatous,Epithelial Cell, Glandular,Epithelial Cell, Squamous,Epithelial Cell, Transitional,Epithelial Cells, Adenomatous,Epithelial Cells, Glandular,Epithelial Cells, Squamous,Epithelial Cells, Transitional,Glandular Epithelial Cell,Squamous Cell,Squamous Epithelial Cell,Transitional Epithelial Cell
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries

Related Publications

Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
December 2006, The Annals of thoracic surgery,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
August 2004, The Journal of thoracic and cardiovascular surgery,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
February 2023, Molecular neurobiology,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
October 2007, Journal of neuroimmunology,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
April 2012, Circulation. Cardiovascular interventions,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
May 2004, Hepatobiliary & pancreatic diseases international : HBPD INT,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
September 2013, Circulation,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
February 2004, Circulation,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
February 2007, Biochemical and biophysical research communications,
Toshio Watanabe, and Tetsuya Tanigawa, and Atsushi Kobata, and Shogo Takeda, and Yuji Nadatani, and Koji Otani, and Hirokazu Yamagami, and Masatsugu Shiba, and Kazunari Tominaga, and Yasuhiro Fujiwara, and Tetsuo Arakawa
June 2019, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Copied contents to your clipboard!